Afficher la notice abrégée

dc.creatorPapatheodoridis, G. V.en
dc.creatorDalekos, G. N.en
dc.creatorYurdaydin, C.en
dc.creatorGoulis, I.en
dc.creatorArends, P.en
dc.creatorButi, M.en
dc.creatorSypsa, V.en
dc.creatorManolakopoulos, S.en
dc.creatorMangia, G.en
dc.creatorGatselis, N.en
dc.creatorKeskin, O.en
dc.creatorSavvidou, S.en
dc.creatorHansen, B. E.en
dc.creatorPapaioannou, C.en
dc.creatorGalanis, K.en
dc.creatorIdilman, R.en
dc.creatorColombo, M.en
dc.creatorEsteban, R.en
dc.creatorJanssen, H. L.en
dc.creatorLampertico, P.en
dc.date.accessioned2015-11-23T10:44:28Z
dc.date.available2015-11-23T10:44:28Z
dc.date.issued2013
dc.identifier.issn0270-9139
dc.identifier.urihttp://hdl.handle.net/11615/31948
dc.source.uri<Go to ISI>://WOS:000330252201190
dc.subjectGastroenterology & Hepatologyen
dc.titleRisk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)en
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée